EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pancreatic Stone Protein in Burns: Clinical Value of Bedside Testing—A Prospective Pilot Study

Moritz Billner iD, Philipp von Imhoff, Konrad Karcz, Vadym Burchak, Maximilian C Stumpfe, Celena A Soergel, Denis Ehrl iD

Diagnostics · 07.07.2026 · 16 (13) · 2129

DOI: 10.3390/diagnostics16132129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 07.07.2026. Verfasst von Moritz Billner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Burn Unit, Department of Plastic, Reconstructive and Hand Surgery, Klinikum Nuremberg Hospital, Paracelsus Medical University, Breslauer Str. 201, 90…. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early detection of severe infections in burn patients is difficult due to confounding sterile inflammation. Previous research has shown that Pancreatic Stone Protein (PSP) is less affected by trauma and surgery. Therefore, this study investigated whether longitudinal PSP trends can distinguish sterile post-burn inflammation from clinically relevant infections and indicate response to antimicrobial therapy.

Methods

This prospective pilot cohort study included 10 consecutive adult patients with moderate to severe burn injuries admitted to a specialized burn intensive care unit. PSP levels were measured using bedside testing (abioSCOPE®) daily over a 14-day observation period. Clinical parameters, burn severity as assessed by the Abbreviated Burn Severity Index (ABSI), and the occurrence of severe infectious complications, including pneumonia and bacteremia, were systematically recorded. PSP measurements were not used to guide clinical decision-making.

Results

Patients who developed severe infectious complications (pneumonia and/or bacteremia; mean ABSI 8.5) showed a consistent and characteristic increase in PSP levels (>350 ng/mL) over time, with elevations preceding the clinical diagnosis of infection (24–120 h). In contrast, patients without pneumonia or bacteremia (mean ABSI 6) exhibited low and stable PSP (

Schlagwörter

Stichwörter der Autor:innen

burn intensive careburnsnosocomial infectionspancreatic stone proteinsepsis biomarkers

Autor:innen und Institutionen

  • Burn Unit, Department of Plastic, Reconstructive and Hand Surgery, Klinikum Nuremberg Hospital, Paracelsus Medical University, Breslauer Str. 201, 90471 Nuremberg, Germany.
  • Division of Hand, Plastic and Aesthetic Surgery University Hospital, Ludwig-Maximilians-Universität Munich, Marchioninistraße 15, 81377 Munich, Germany.

ORCID-Profile: Moritz Billner, Denis Ehrl

Zitieren

APA

Billner, M., Imhoff, P. V., Karcz, K., Burchak, V., Stumpfe, M. C., Soergel, C. A., & Ehrl, D. (2026). Pancreatic Stone Protein in Burns: Clinical Value of Bedside Testing—A Prospective Pilot Study. Diagnostics, 16(13), 2129. https://doi.org/10.3390/diagnostics16132129

Vancouver

Billner M, Imhoff PV, Karcz K, Burchak V, Stumpfe MC, Soergel CA, et al. Pancreatic Stone Protein in Burns: Clinical Value of Bedside Testing—A Prospective Pilot Study. Diagnostics. 2026;16(13):2129. doi:10.3390/diagnostics16132129

BibTeX
@article{Billner2026,
  author = {Billner, Moritz and Imhoff, Philipp von and Karcz, Konrad and Burchak, Vadym and Stumpfe, Maximilian C and Soergel, Celena A and Ehrl, Denis},
  title = {Pancreatic Stone Protein in Burns: Clinical Value of Bedside Testing—A Prospective Pilot Study},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {13},
  pages = {2129},
  doi = {10.3390/diagnostics16132129}
}
Kostenlos starten →